Onyx Biotec Limited (NSE:ONYX)

Market Cap	580.23M
Revenue (ttm)	663.87M
Net Income (ttm)	10.68M
Shares Out	18.13M
EPS (ttm)	0.65
PE Ratio	49.39
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,000
Average Volume	16,600
Open	32.20
Previous Close	32.00
Day's Range	32.00 - 32.20
52-Week Range	28.10 - 80.00
Beta	n/a
RSI	39.61
Earnings Date	Feb 12, 2026

About Onyx Biotec

Onyx Biotec Limited develops, manufactures, and distributes generic and proprietary pharmaceutical products in India and internationally. The company offers water for injections (WFI), dry powder injections, and dry powder syrup. It also exports its products. Onyx Biotec Limited was incorporated in 2005 and is based in Chandigarh, India.

• Industry: Pharmaceutical Preparations
• Founded: 2005
• Employees: 357
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ONYX

Financial Performance

In 2024, Onyx Biotec's revenue was 619.51 million, an increase of 15.26% compared to the previous year's 537.49 million. Earnings were 49.54 million, an increase of 36.31%.